Minerva Neurosciences Inc (NASDAQ: NERV) Submits New Drug Application for Roluperidone...

Max - 0

Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) Announces EMA Marketing Authorization Validation...

Max - 0

Ginkgo Bioworks Holdings Inc (NYSE: DNA) Acquires Strategic Epidemiological Information Infrastructure...

Max - 0

The US FDA Approves Axsome Therapeutics Inc’s (NASDAQ: AXSM) AUVELITY For...

Max - 0

Palisade Bio Inc (NASDAQ: PALI) Commences Dosing Of Patients In Phase...

Max - 0

Sorrento Therapeutics Inc (NASDAQ: SRNE) Receives NMPA Authorization of Phase 1...

Max - 0

Liquidia Corporation (NASDAQ: LQDA) Announce Revenue of $3.9 million in Q2...

Max - 0

VistaGen Therapeutics Inc (NASDAQ: VTGN) Reports Q1 2023 Financial Results And...

Max - 0

Mind Medicine (MindMed) Inc (NASDAQ: MNMD) Doses First Patient on Phase...

Max - 0

Kiora Pharmaceuticals Inc (NASDAQ: KPRX) Announces Financial Results For Quarter and...

Max - 0
1...363738...248Page 37 of 248